Skip to content
AACR 2026 现场信号· @ · X·· 2026-04-22Score60
Body · original

Our team recently attended the @AACR Annual Meeting in San Diego! Thanks to Tongfei Wu and Heleen Roose for sharing preclinical data on our oral PD-L1 small molecule inhibitors, ALG-093940 and ALG-094295 in a poster presentation. #AACR26 https://t.co/4JFOGVA6mb

Heat 0 · 0 likes · 0 replies · 0 reposts

Conference abstracts
2818matched by 代号 ALG-094295
Preclinical Characterization of ALG-094295, a highly potent and orally bioavailable small molecule PD-1/PD-L1 inhibitor targeting dimerization, internalization and degradation of PD-L1

Heleen Roose, Kristina Rekstyte-Matiene, Sarah Stevens, Kusum Gupta, Sandra Chang, Nour Fayyad, Cheng Liu, Vladimir Serebryany, Lillian Adame, Kha Le, Antitsa Stoycheva, Dinah Misner, Lawrence M. Blatt, Sushmita Chanda, David B. Smith, Julian A. Symons, Andreas Jekle, Tongfei Wu

Read the abstract →
2819matched by 代号 ALG-093940
Preclinical characterization of ALG-093940, a potent and orally bioavailable small molecule PD-1/PD-L1 inhibitor targeting PD-L1 dimerization, internalization and degradation

Heleen Roose, Kristina Rekstyte-Matien, Sarah Stevens, Kusum Gupta, Sandra Chang, Nour Fayyad, Cheng Liu, Vladimir Serebryany, Lillian Adame, Kha Le, Antitsa Stoycheva, Dinah Misner, Lawrence M. Blatt, Leonid Beigelman, Sushmita Chanda, David B. Smith, Julian A. Symons, Andreas Jekle, Tongfei Wu

Read the abstract →

Source: AACR 2026 现场信号 · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org